Evicenter
Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer
Manufacturer
Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP
Prescribing information
Datroway (opens in a new tab)
Questions
42
Last updated

All questions

Specific populations: Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer

5 questions · 1 source

Specific populations

Can DATROWAY be used during pregnancy or breastfeeding?

How long is contraception needed after DATROWAY?

Does DATROWAY affect fertility?

Does DATROWAY require dose adjustment for kidney or liver impairment?

Is DATROWAY safe for patients 65 and older?